Hongda Liu
1
Miao Liu
2*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Oncol.
Sec. Thoracic Oncology
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1481799
This article is part of the Research Topic Novel Biomarkers for Potential Clinical Applications in Lung Cancer View all 41 articles
Editorial: Novel Biomarkers for Potential Clinical Applications in Lung Cancer
Provisionally accepted- 1 Nanjing Medical University, Nanjing, Jiangsu Province, China
- 2 Harvard Medical School, Boston, United States
Keywords: lung cancer, prognosis, biomarker, clinical application, Signal pathway
Received: 16 Aug 2024; Accepted: 30 Aug 2024.
Copyright: © 2024 Liu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Miao Liu, Harvard Medical School, Boston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.